PPA
OLMA icon

Parametric Portfolio Associates’s Olema Pharmaceuticals OLMA Stock Holding History

Parametric Portfolio Associates’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$740K Buy
173,761
+134,474
+342% +$741K ﹤0.01% 2916
2021
Q4 		$368K Buy
39,287
+11,675
+42% +$242K ﹤0.01% 3199
2021
Q3 		$761K Buy
27,612
+1,351
+5% +$36.5K ﹤0.01% 2918
2021
Q2 		$735K Sell
26,261
-3,898
-13% -$111K ﹤0.01% 2914
2021
Q1 		$1M Buy
30,159
+5,519
+22% +$237K ﹤0.01% 3161
2020
Q4 		$1.19M Buy
+24,640
New +$1.16M ﹤0.01% 2959

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Parametric Portfolio Associates's OLMA Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Olema Pharmaceuticals (OLMA) stake by 342% in Q1 2022, buying an estimated $741K and bringing the position to 173,761 shares worth $740K. The position accounts for ﹤0.01% of the portfolio, ranked #2916.

Parametric Portfolio Associates first reported a position in OLMA in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.19M in Q4 2020. 91 funds tracked by Wall St. Rank hold OLMA as of Q1 2022.

  • Parametric Portfolio Associates held 173,761 shares of Olema Pharmaceuticals worth $740K as of Q1 2022.
  • Parametric Portfolio Associates bought 134,474 Olema Pharmaceuticals shares in Q1 2022, an estimated $741K.
  • Olema Pharmaceuticals made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2916 holding.
  • Parametric Portfolio Associates first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 6 quarters since.
  • Parametric Portfolio Associates's Olema Pharmaceuticals position peaked at $1.19M in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.